SS-31
FDA-approved (Rx)Also known as: Elamipretide, Forzinity
Category: Longevity
Sold as:
Ameano Peptides: §-31
Nexaph: NXP-ATP
Peptide that targets the inner membrane of mitochondria to support energy production. Ameano's "§-31" and Nexaph's "NXP-ATP" (both 30 mg vials) appear to be this compound, but neither product page says so.
What it's used for
- Barth syndrome, a rare mitochondrial disease (FDA accelerated approval)
- Research interest in muscle weakness, heart function and aging
Dosing
- Typical dose
- Approved label dose for Barth syndrome is 40 mg once daily. There is no established dose for other uses.
- How often
- Once daily
- Route
- Subcutaneous injection
- Cycle length
- Continuous for the approved use
Build a dosing plan for SS-31 →
How to reconstitute and measure a dose → · About bacteriostatic water →
Possible side effects
- Injection site reactions, which are very common
- Headache, dizziness
Important: Approved only for Barth syndrome. Confirm with the seller what "§-31" or "NXP-ATP" contains before use.